Estrogen Receptor (ER)-Positive, HER2-negative, Locally Advanced or Metastatic Breast Canc Clinical Trials

Estrogen Receptor (ER)-Positive, HER2-negative, Locally Advanced or Metastatic Breast Cancer

Explore clinical trials studying Estrogen Receptor (ER)-Positive, HER2-negative, Locally Advanced or Metastatic Breast Cancer. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Estrogen Receptor (ER)-Positive, HER2-negative, Locally Advanced or Metastatic Breast Cancer trial results

Active, Not Recruiting

A Study Evaluating the Efficacy and Safety of Giredestrant Plus Everolimus Compared With the Physician's Choice of Endocrine Therapy Plus Everolimus in Participants With Estrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer (evERA Breast Cancer)

NCT05306340

Conditions: Breast Diseases, Breast Neoplasms, Estrogen Receptor (ER)-Positive, HER2-negative, Locally Advanced or Metastatic Breast Cancer, +4 more
Locations: Alaska Oncology & Hematology, LLC Anchorage, Alaska, United States

Arizona Oncology Associates, PC-CASA Tucson, Arizona, United States

University of Arkansas for Medical Sciences Little Rock, Arkansas, United States

Alta Bates Summit Medical Center Berkeley, California, United States

View all 136 locations

View Trial Details

Related conditions